Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.24.3
Stockholders' Equity (Tables)
 3 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity:

 

 

Options

 

 

Weighted-Average Exercise Price Per Share

 

 

Aggregate
Intrinsic Value
(in thousands)

 

 

Weighted-Average Grant Date Fair Value Per Award (1)

 

Fiscal 2024

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2023

 

 

1,446,260

 

 

$

7.11

 

 

$

43,882

 

 

$

3.58

 

Exercises

 

 

(174,295

)

 

$

5.82

 

 

$

4,985

 

 

$

3.54

 

Outstanding at September 30, 2023

 

 

1,271,965

 

 

$

7.29

 

 

$

28,144

 

 

$

3.59

 

Exercisable at September 30, 2023

 

 

1,087,963

 

 

$

5.29

 

 

$

26,150

 

 

$

2.71

 

Fiscal 2025

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

1,158,530

 

 

$

7.10

 

 

$

29,354

 

 

$

3.53

 

Exercises

 

 

(230,668

)

 

$

14.23

 

 

$

6,828

 

 

$

6.56

 

Outstanding at September 30, 2024

 

 

927,862

 

 

$

5.32

 

 

$

36,035

 

 

$

2.78

 

Exercisable at September 30, 2024

 

 

922,862

 

 

$

5.14

 

 

$

36,012

 

 

$

2.70

 

 

(1) The Company issued the options with an exercise price per share not less than the closing market price of common stock on the grant date.
Summary of Information about Stock Option

The following table summarizes information about stock options as of September 30, 2024:

Exercise Price Ranges

 

 

Options Outstanding

 

 

Options Exercisable

 

From

 

 

To

 

 

Number of
 Underlying
 Shares

 

 

Weighted-Average Remaining Contractual Life
(Years)

 

 

Weighted-Average Exercise Price

 

 

Number of
 Underlying
 Shares

 

 

Weighted-Average Remaining Contractual Life
(Years)

 

 

Weighted-Average Exercise Price

 

$

—

 

 

$

5.00

 

 

 

559,862

 

 

 

4.91

 

 

$

1.96

 

 

 

559,862

 

 

 

4.91

 

 

$

1.96

 

$

5.01

 

 

$

7.50

 

 

 

15,000

 

 

 

2.03

 

 

$

6.33

 

 

 

15,000

 

 

 

2.03

 

 

$

6.33

 

$

7.51

 

 

$

12.50

 

 

 

301,000

 

 

 

1.39

 

 

$

8.96

 

 

 

301,000

 

 

 

1.39

 

 

$

8.96

 

$

12.51

 

 

$

30.00

 

 

 

42,000

 

 

 

6.28

 

 

$

15.51

 

 

 

42,000

 

 

 

6.28

 

 

$

15.51

 

$

30.01

 

 

$

50.00

 

 

 

10,000

 

 

 

8.35

 

 

$

39.69

 

 

 

5,000

 

 

 

8.35

 

 

$

39.69

 

 

 

 

 

 

 

927,862

 

 

 

3.82

 

 

$

5.32

 

 

 

922,862

 

 

 

3.80

 

 

$

5.14

 
Summary of Nonvested Stock Option Activity

The following table summarizes nonvested stock option activity:

 

 

Options

 

 

 

Weighted-Average Grant Date Fair Value Per Award

 

Nonvested outstanding at June 30, 2024

 

 

41,664

 

 

 

$

9.23

 

Vested

 

 

(36,664

)

 

 

$

8.23

 

Nonvested outstanding at September 30, 2024

 

 

5,000

 

 

 

$

16.56

 
Summary of Restricted Stock Unit Activity

The following table summarizes RSU activity:

 

 

Awards
Outstanding

 

 

 

Weighted-Average Fair Value per Unit at Grant Date

 

 

Fiscal 2024

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2023

 

 

63,587

 

 

 

$

32.37

 

 

Granted (as deemed reinvestment of cash dividend equivalents)

 

 

285

 

 

 

$

—

 

 (1)

Vested & delivered

 

 

(6,439

)

 

 

$

31.06

 

 

Vested & deferred (2)

 

 

(205

)

 

 

$

—

 

 (1)

Nonvested outstanding at September 30, 2023

 

 

57,228

 

 

 

$

32.48

 

 

Vested but subject to deferred settlement at September 30, 2023 (2)

 

 

29,575

 

 

 

$

24.33

 

 

Outstanding at September 30, 2023

 

 

86,803

 

 

 

$

29.70

 

 

Fiscal 2025

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2024 (3)

 

 

61,317

 

 

 

$

30.61

 

 

Granted (as deemed reinvestment of cash dividend equivalents)

 

 

52

 

 

 

$

—

 

 (1)

Vested & deferred (2)

 

 

(40

)

 

 

$

—

 

 (1)

Nonvested outstanding at September 30, 2024 (3)

 

 

61,329

 

 

 

$

30.61

 

 

Vested but subject to deferred settlement at September 30, 2024 (2)

 

 

41,987

 

 

 

$

26.03

 

 

Outstanding at September 30, 2024 (3)

 

 

103,316

 

 

 

$

28.75

 

 

 

(1) These shares were granted upon deemed reinvestment of dividend equivalents, in accordance with mandatory terms of the award agreement. The measured fair value of the original award fully valued the participant’s right to deemed reinvestment of dividend equivalents, and therefore this grant resulted in no incremental compensation expense, which is reflected in the table as zero fair value for the shares.

(2) Certain RSU holders elected to defer settlement of the RSUs to a specified date. The DSU holder is contractually obligated to defer settlement of the DSUs to a specified date following the holder’s termination of service.

(3) Includes 6,265 RSUs that vest based on continuous employment and achievement of non-market performance goals through June 30, 2025, and 2026.